Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Mar 2024 |
---|---|---|---|---|
Total reported revenue | — | 5.6B | 6.5B | 7.4B |
Cost of revenue | — | 4.2B | 4.6B | 5.5B |
Gross profit | — | 1.4B | 1.9B | 1.9B |
Operating expense | ||||
Research & development | — | 208.5M | — | 123.6M |
Selling general and admin | — | 174.2M | 1.0B | 225.1M |
Other operating expenses | — | 79.2M | — | 42.9M |
Operating income | — | 297.3M | 846.5M | 937.5M |
Non operating interest income | ||||
Income | — | 285.9M | — | 161.5M |
Expense | — | 60.7M | — | 72.9M |
Other income expense | — | — | — | — |
Pretax income | — | 437.7M | 996.2M | 1.0B |
Tax provision | — | -158.1M | 149.5M | 216.5M |
Net income | — | 595.8M | 846.7M | 809.0M |
Basic EPS | — | — | 199 | 190 |
Diluted EPS | — | — | 199 | 190 |
Basic average shares | — | — | 4.3M | 4.3M |
Diluted average shares | 5.3M | — | 4.3M | 4.3M |
EBITDA | — | 761.5M | 846.5M | 1.3B |
Net income from continuing op. | — | 595.8M | — | 809.0M |
Minority interests | — | — | — | — |
Preferred stock dividends | — | — | — | — |